SAB Biotherapeutics, Inc. (SABS)
3.60
+0.03
(+0.84%)
USD |
NASDAQ |
May 29, 16:00
3.60
0.00 (0.00%)
Pre-Market: 20:00
SAB Biotherapeutics Total Assets (Quarterly) : 248.47M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.179B |
| Anixa Biosciences, Inc. | 15.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.22M |
| Shareholders Equity (Quarterly) | 227.25M |
| Debt to Equity Ratio | 0.0272 |
| Current Ratio | 11.45 |
| Net Debt Paydown Yield | -0.10% |